Alpha 2.0
Login Register
» Articles » PMID: 23601137

Everolimus with Reduced Tacrolimus in Liver Transplantation

Overview
Journal Am J Transplant
Publisher Elsevier
Specialty General Surgery
Date 2013 Apr 23
PMID 23601137
Citations 3
Authors
P De Simone
S Beckebaum
B Koneru
J Fung
F Saliba
Affiliations
Soon will be listed here.
Citing Articles

Renal Protective Effect of Everolimus in Liver Transplantation: A Prospective Randomized Open-Label Trial.

Kadry Z, Stine J, Dohi T, Jain A, Robyak K, Kwon O Transplant Direct. 2021; 7(7):e709.

PMID: 34124345 PMC: 8191692. DOI: 10.1097/TXD.0000000000001159.

Cardiovascular Disease Outcomes Related to Early Stage Renal Impairment After Liver Transplantation.

VanWagner L, Montag S, Zhao L, Allen N, Lloyd-Jones D, Das A Transplantation. 2018; 102(7):1096-1107.

PMID: 29557907 PMC: 6023752. DOI: 10.1097/TP.0000000000002175.

Everolimus Is Associated With Less Weight Gain Than Tacrolimus 2 Years After Liver Transplantation: Results of a Randomized Multicenter Study.

Charlton M, Rinella M, Patel D, McCague K, Heimbach J, Watt K Transplantation. 2017; 101(12):2873-2882.

PMID: 28817434 PMC: 5704647. DOI: 10.1097/TP.0000000000001913.